title: Part 1: Defining unproven cellular therapies.
authors.affiliation: Center for Stem Cell Research (a unit of inStem, Bengaluru), Department of Hematology, Christian Medical College, Vellore, India. Member at large of the ISCT Presidential Task Force on the Use of Unproven Cellular Therapies. Electronic address: aloks@cmcvellore.ac.in.
authors.forename: Alok
authors.initials: A
authors.lastname: Srivastava
authors.affiliation: Advanced Centre for Biochemical Engineering, University College London, London, United Kingdom. Member at large of the ISCT Presidential Task Force on the Use of Unproven Cellular Therapies.
authors.forename: Chris
authors.initials: C
authors.lastname: Mason
authors.affiliation: Voorburg, Netherlands. ISCT Europe, Regional Vice President 2014-2016.
authors.forename: Edwin
authors.initials: E
authors.lastname: Wagena
authors.affiliation: Andalusian Initiative for Advanced Therapies, Junta de Andalucía, Sevilla, Spain. Chair, ISCT EU LRA Committee, 2014-2016.
authors.forename: Natividad
authors.initials: N
authors.lastname: Cuende
authors.affiliation: Department of Medicine, University of Vermont, Burlington, Vermont, USA. ISCT Chief Scientific Officer 2014-2016. Chair, ISCT Pulmonary Committee 2013-2015.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Weiss
authors.affiliation: Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, Departments of Pediatrics and Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA. ISCT Past President 2010-2012.
authors.forename: Edwin M
authors.initials: EM
authors.lastname: Horwitz
authors.affiliation: Division of Oncology, Laboratory of Cellular Therapy, University of Modena & Reggio Emilia, Modena, Italy. ISCT President 2014-2016. Chair, ISCT Presidential Task Force on the Use of Unproven Cellular Therapies.
authors.forename: Massimo
authors.initials: M
authors.lastname: Dominici